Pharmaceutical The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended new measures to minimize the risk of meningioma with medicines containing nomegestrol or chlormadinone, which are used for gynecological and menstrual disorders, hormone replacement therapy and, at lower doses, as hormonal contraceptives (birth control). 8 July 2022